Donald Trump offers to mediate between India and Pakistan on Kashmir issue
Washington, Jul 22: US President Donald Trump on Monday offered to mediate between India and Pakistan on the Kashmir issue as he met Prime Minister Imran Khan at the White House for the first time.
Trump said that he is ready to help, if the two countries ask.
"If I can help, I would love to be a mediator," Trump said in his opening remarks at the Oval Office during his meeting with Khan.
Khan welcomed Trump's remarks and said if the US agrees, prayers of more than a billion people will be with him.
India maintains that the Kashmir issue is a bilateral one and no third party has any role.
India has not been engaging with Pakistan since an attack on the Air Force base at Pathankot in January of 2016 by Pakistan-based terrorists, maintaining that talks and terror cannot go together.
Khan was accompanied by Army chief General Qamar Javed Bajwa, Inter-Services Intelligence (ISI) chief Lt Gen Faiz Hameed and Foreign Minister Shah Mehmood Qureshi among others.
Early this year, tensions flared up between India and Pakistan after a suicide bomber of Pakistan-based Jaish-e-Muhammed (JeM) killed 40 CRPF personnel in Kashmir's Pulwama district.
Amid mounting outrage, the Indian Air Force carried out a counter-terror operation, hitting the biggest JeM training camp in Balakot, deep inside Pakistan on February 26.
The next day, Pakistan Air Force retaliated and downed a MiG-21 in an aerial combat and captured Indian pilot, who was handed over to India on March 1.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Jamia prof receives Rs 94 lakh grant to formulate AI-driven drug to treat breast cancer
New Delhi (PTI): An associate professor at Jamia Millia Islamia has been awarded a research grant of approximately Rs 94 lakh by the prestigious ICMR to support research in leveraging Artificial Intelligence for treatment of breast cancer.
The Indian Council of Medical Research (ICMR) has granted funding to Raza to develop cutting-edge tools for AI-guided drug design, focusing on optimising drug compounds, identifying therapeutic targets, and formulating novel treatment strategies for breast cancer, a statement by the varsity said on Friday.
One such promising drug compound 'DdpMPyPEPhU' already patented by Raza will be further explored under this initiative, the statement said.
This research will address critical challenges in breast cancer treatment and is expected to yield transformative outcomes that could impact healthcare practices globally, it added.
The three-year funding will facilitate advanced experimentation, foster collaboration with leading experts, and accelerate the development of innovative solutions for breast cancer treatment.
Jamia Vice-Chancellor Mazhar Asif and Registrar Md. Mahtab Alam Rizvi congratulated Raza on this accomplishment.
Asif stated, “This is a moment of immense pride for JMI. Raza’s recognition by ICMR underscores the university’s commitment to fostering research excellence and innovation. His groundbreaking work showcases JMI’s vital contributions to integrating AI in healthcare research.”
Expressing gratitude for the recognition, Raza said, “I am deeply honoured to receive this grant from ICMR. It represents a tremendous opportunity to advance our research on AI- driven drug design and contribute to better health outcomes for millions. I am thankful to my research team, collaborators and ICMR for their unwavering support.”
Raza is known for his research in the application of AI in healthcare, focusing on designing and optimising drug compounds through AI-based multitarget docking, molecular simulations, and genomics-driven personalised medicine.
